Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
14 Apr 2020
Historique:
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (Covid-19), an evolving pandemic. Limited data are available characterizing SARS-Cov-2 infection in the United States. To determine associations between demographic and clinical factors and testing positive for coronavirus 2019 (Covid-19+), and among Covid-19+ subsequent hospitalization and intensive care. Retrospective cohort study including all patients tested for Covid-19 between February 8 and March 30, 2020, inclusive. We extracted electronic health record data from the national Veterans Affairs Healthcare System, the largest integrated healthcare system in the United States, on 2,026,227 patients born between 1945 and 1965 and active in care. Exposures: Demographic data, comorbidities, medication history, substance use, vital signs, and laboratory measures. Laboratory tests were analyzed first individually and then grouped into a validated summary measure of physiologic injury (VACS Index). Main Outcomes and Measures: We evaluated which factors were associated with Covid-19+ among all who tested. Among Covid-19+ we identified factors associated with hospitalization or intensive care. We identified independent associations using multivariable and conditional multivariable logistic regression with multiple imputation of missing values. Among Veterans aged 54-75 years, 585/3,789 (15.4%) tested Covid-19+. In adjusted analysis (C-statistic=0.806) black race was associated with Covid-19+ (OR 4.68, 95% CI 3.79-5.78) and the association remained in analyses conditional on site (OR 2.56, 95% CI 1.89-3.46). In adjusted models, laboratory abnormalities (especially fibrosis-4 score [FIB-4] >3.25 OR 8.73, 95% CI 4.11-18.56), and VACS Index (per 5-point increase OR 1.62, 95% CI 1.43-1.84) were strongly associated with hospitalization. Associations were similar for intensive care. Although significant in unadjusted analyses, associations with comorbid conditions and medications were substantially reduced and, in most cases, no longer significant after adjustment. Black race was strongly associated with Covid-19+, but not with hospitalization or intensive care. Among Covid-19+, risk of hospitalization and intensive care may be better characterized by laboratory measures and vital signs than by comorbid conditions or prior medication exposure.

Identifiants

pubmed: 32511595
doi: 10.1101/2020.04.09.20059964
pmc: PMC7276022
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026224
Pays : United States
Organisme : NIAAA NIH HHS
ID : U10 AA013566
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020790
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA020794
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

AIDS. 2019 Apr 1;33(5):903-912
pubmed: 30649058
Am J Public Health. 2018 Mar;108(3):e1-e11
pubmed: 29412713
JAMA. 2020 Apr 6;:
pubmed: 32250385
Lancet. 2020 Mar 28;395(10229):1014-1015
pubmed: 32197108
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Hepatology. 2006 Feb;43(2 Suppl 1):S54-62
pubmed: 16447271
BMJ. 2020 Mar 17;368:m1086
pubmed: 32184201
Eur J Gastroenterol Hepatol. 2001 Jul;13(7):777-84
pubmed: 11474306
Nat Rev Gastroenterol Hepatol. 2016 Feb;13(2):88-110
pubmed: 26758786
J Hepatol. 2016 Aug;65(2):259-65
pubmed: 27130843
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Nicotine Tob Res. 2011 Dec;13(12):1233-9
pubmed: 21911825
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Med Care. 2019 Apr;57(4):279-285
pubmed: 30807449
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386
pubmed: 32240123
JAMA. 2020 Feb 24;:
pubmed: 32091533
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
J Rural Health. 2010 Fall;26(4):310-7
pubmed: 21029165
Am J Public Health. 2009 Oct;99 Suppl 2:S261-70
pubmed: 19797739
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1023-1033
pubmed: 31565954
Hepatology. 2006 Jun;43(6):1317-25
pubmed: 16729309

Auteurs

Christopher T Rentsch (CT)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK, WC1E 7HT.

Farah Kidwai-Khan (F)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, US, 06520.

Janet P Tate (JP)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, US, 06520.

Lesley S Park (LS)

Stanford Center for Population Health Sciences, Stanford University School of Medicine, Stanford, CA, US, 94305.

Joseph T King (JT)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Department of Neurosurgery, Yale School of Medicine, New Haven, CT, US, 06520.

Melissa Skanderson (M)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.

Ronald G Hauser (RG)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, US, 06520.

Anna Schultze (A)

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK, WC1E 7HT.

Christopher I Jarvis (CI)

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK, WC1E 7HT.

Mark Holodniy (M)

VA Palo Alto Healthcare System, US Department of Veterans Affairs, Palo Alto, CA, US, 94304.
Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, US, 94305.

Vincent Lo Re (VL)

Division of Infectious Diseases, Department of Medicine and Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, US, 19104.

Kathleen M Akgün (KM)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, US, 06520.

Kristina Crothers (K)

VA Puget Sound Health Care System and Department of Medicine, University of Washington School of Medicine, Seattle, WA, US, 98104.

Tamar H Taddei (TH)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, US, 06520.

Matthew S Freiberg (MS)

Geriatric Research Education and Clinical Center (GRECC), US Department of Veterans Affairs, Tennessee Valley Health Care System, Nashville, TN, US 37212.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, US, 37232.

Amy C Justice (AC)

VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, US, 06516.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, US, 06520.
Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, US, 06511.

Classifications MeSH